A TGF-β1 polymorphism association with dementia and neuropathologies: The HAAS

Neurobiology of Aging

Volumn 28, Issue 9, 2007, Pages 1367-1373

  Peila, Rita ^a,b   Yucesoy, Berran ^c   White, Lon R ^b,d   Johnson, Victor ^c   Kashon, Michael L ^c   Wu, Kim ^a   Petrovitch, Helen ^b   Luster, Michael ^c   Launer, Lenore J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

Cerebral microinfarcts; Dementia; Transforming growth factor 1

Indexed keywords

CYTOSINE; THYMINE; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ARTICLE; AUTOPSY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; UNITED STATES; VASCULAR AMYLOIDOSIS; ASIAN AMERICAN; CHI SQUARE DISTRIBUTION; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETICS; GERIATRIC ASSESSMENT; HOSPITALIZATION; LONGITUDINAL STUDY; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ASIAN AMERICANS; AUTOPSY; CEREBRAL AMYLOID ANGIOPATHY; CHI-SQUARE DISTRIBUTION; DEMENTIA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; GERIATRIC ASSESSMENT; HAWAII; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34447577984     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.06.004     Document Type: Article

References (41)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd revised ed. American Psychiatric Association; 1987.
2. Cambien F., Ricard S., Troesch A., Mallet C., Generenaz L., Evans A., et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28 5 (1996) 881-887
3. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., and Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42 3 Pt 1 (1992) 473-480
4. Derynck R., Jarrett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian R.K., et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316 6030 (1985) 701-705
5. Devlin B., and Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 2 (1995) 311-322
6. Finch C.E., Laping N.J., Morgan T.E., Nichols N.R., and Pasinetti G.M. TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem 53 4 (1993) 314-322
7. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8 1 (1999) 93-97
8. Graves A.B.L.E., Kukull W.A., et al. Screening for dementia in the community in cross-national studies: comparison between the cognitive abilities screening instrument and the mini-metanl state examination. In: Corain B.I.K., Nicolini M., Winbald B., Wisniewski H., and Zatta P. (Eds). Alzheimer's disease: advances in clinical and basic research (1993), John Wiley & Sons, New York, NY 113-119
9. Gross C.E., Bednar M.M., Howard D.B., and Sporn M.B. Transforming growth factor-beta 1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke 24 4 (1993) 558-562
10. Gross C.E., Howard D.B., Dooley R.H., Raymond S.J., Fuller S., and Bednar M.M. TGF-beta 1 post-treatment in a rabbit model of cerebral ischaemia. Neurol Res 16 6 (1994) 465-470
11. Hamaguchi T., Okino S., Sodeyama N., Itoh Y., Takahashi A., Otomo E., et al. Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 76 5 (2005) 696-699
12. Havlik R.J., Izmirlian G., Petrovitch H., Ross G.W., Masaki K., Curb J.D., et al. APOE-epsilon4 predicts incident AD in Japanese-American men: the honolulu-asia aging study. Neurology 54 7 (2000) 1526-1529
13. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 3 (1990) 545-548
14. Johnson V.J., Yucesoy B., and Luster M.I. Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology. Cytokine 27 6 (2004) 135-141
15. Kagan A., Popper J., Reed D.M., MacLean C.J., and Grove J.S. Trends in stroke incidence and mortality in Hawaiian Japanese men. Stroke 25 6 (1994) 1170-1175
16. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21 2 (2000) 321-330
17. Kenny D., Coughlan M.G., Pagel P.S., Kampine J.P., and Warltier D.C. Transforming growth factor beta 1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusion. Am Heart J 127 6 (1994) 1456-1461
18. Klempt N.D., Sirimanne E., Gunn A.J., Klempt M., Singh K., Williams C., et al. Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain. Brain Res Mol Brain Res 13 1-2 (1992) 93-101
19. Lario S., Inigo P., Campistol J.M., Poch E., Rivera F., and Oppenheimer F. Restriction enzyme-based method for transforming growth factor-beta(1) genotyping: nonisotopic detection of polymorphisms in codons 10 and 25 and the 5′-flanking region. Clin Chem 45 8 Pt 1 (1999) 1290-1292
20. Luedecking E.K., DeKosky S.T., Mehdi H., Ganguli M., and Kamboh M.I. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet 106 5 (2000) 565-569
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
22. McNeill H., Williams C., Guan J., Dragunow M., Lawlor P., Sirimanne E., et al. Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. Neuroreport 5 8 (1994) 901-904
23. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 4 (1991) 479-486
24. Newman A.B., Sutton-Tyrrell K., Vogt M.T., and Kuller L.H. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 270 4 (1993) 487-489
25. Newton-Cheh C., and Hirschhorn J.N. Genetic association studies of complex traits: design and analysis issues. Mutat Res 573 1-2 (2005) 54-69
26. Petrovitch H., Ross G.W., Steinhorn S.C., Abbott R.D., Markesbery W., Davis D., et al. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 57 1 (2005) 98-103
27. Petrovitch H., White L.R., Ross G.W., Steinhorn S.C., Li C.Y., Masaki K.H., et al. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology 57 2 (2001) 226-234
28. Prehn J.H., Backhauss C., and Krieglstein J. Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cereb Blood Flow Metab 13 3 (1993) 521-525
29. Sugiura Y., Niimi T., Sato S., Yoshinouchi T., Banno S., Naniwa T., et al. Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis. Ann Rheum Dis 61 9 (2002) 826-828
30. Suthanthiran M., Li B., Song J.O., Ding R., Sharma V.K., Schwartz J.E., et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 97 7 (2000) 3479-3484
31. Syme S.L., Marmot M.G., Kagan A., Kato H., and Rhoads G. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction. Am J Epidemiol 102 6 (1975) 477-480
32. Teng E.L., Hasegawa K., Homma A., Imai Y., Larson E., Graves A., et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6 1 (1994) 45-58 discussion 62
33. Vinters H.V., and Gilbert J.J. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14 6 (1983) 924-928
34. White L., Petrovitch H., Hardman J., Nelson J., Davis D.G., Ross G.W., et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 977 (2002) 9-23
35. White L., Petrovitch H., Ross G.W., Masaki K.H., Abbott R.D., Teng E.L., et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA 276 12 (1996) 955-960
36. Williams C., Guan J., Miller O., Beilharz E., McNeill H., Sirimanne E., et al. The role of the growth factors IGF-1 and TGF beta 1 after hypoxic-ischemic brain injury. Ann NY Acad Sci 765 (1995) 306-307
37. World Health Organization. Diabetes mellitus: report of a WHO study group. Geneva: WHO; 1985. Report number 727.
38. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., et al. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature 389 6651 (1997) 603-606
39. Yamada Y., Miyauchi A., Goto J., Takagi Y., Okuizumi H., Kanematsu M., et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13 10 (1998) 1569-1576
40. Yokota M., Ichihara S., Lin T.L., Nakashima N., and Yamada Y. Association of a T29 → C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101 24 (2000) 2783-2787
41. Yucesoy B., Peila R., White L.R., Wu K.M., Johnson V.J., Kashon M.L., et al. Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiol Aging (2005)